Compile Data Set for Download or QSAR
maximum 50k data
Found 22 Enz. Inhib. hit(s) with all data for entry = 8280
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM5446(CHEMBL553 | ERLOTINIB HYDROCHLORIDE | Erlotinib | ...)
Affinity DataIC50:  30nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424964(CHEMBL2316151 | US9409845, Table 1, Compound 12: (...)
Affinity DataIC50:  430nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424973(CHEMBL2316142 | US9409845, Table 1, Compound 3: (2...)
Affinity DataIC50:  1.54E+3nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424975(CHEMBL2316140 | US9409845, Table 1, Compound 1: (2...)
Affinity DataIC50:  1.68E+3nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424957(CHEMBL2316158 | US9409845, Table 1, Compound 19: (...)
Affinity DataIC50:  1.96E+3nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424958(CHEMBL2316157 | US9409845, Table 1, Compound 18: (...)
Affinity DataIC50:  2.08E+3nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424972(CHEMBL2316143 | US9409845, Table 1, Compound 4: (2...)
Affinity DataIC50:  2.17E+3nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424974(CHEMBL2316141 | US9409845, Table 1, Compound 2: (2...)
Affinity DataIC50:  2.27E+3nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424961(CHEMBL2316154 | US9409845, Table 1, Compound 15: (...)
Affinity DataIC50:  3.98E+3nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424962(CHEMBL2316153 | US9409845, Table 1, Compound 14: (...)
Affinity DataIC50:  4.66E+3nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424956(CHEMBL2316159 | US9409845, Table 1, Compound 20: (...)
Affinity DataIC50:  4.81E+3nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424960(CHEMBL2316155 | US9409845, Table 1, Compound 16: (...)
Affinity DataIC50:  5.37E+3nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424968(CHEMBL2316147 | US9409845, Table 1, Compound 8: (2...)
Affinity DataIC50:  5.69E+3nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424965(CHEMBL2316150 | US9409845, Table 1, Compound 11: (...)
Affinity DataIC50:  6.13E+3nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424970(CHEMBL2316145 | US9409845, Table 1, Compound 6: (2...)
Affinity DataIC50:  6.85E+3nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424969(CHEMBL2316146 | US9409845, Table 1, Compound 7: (2...)
Affinity DataIC50:  7.12E+3nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424966(CHEMBL2316149 | US9409845, Table 1, Compound 10: (...)
Affinity DataIC50:  7.52E+3nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424971(CHEMBL2316144 | US9409845, Table 1, Compound 5: (2...)
Affinity DataIC50:  8.08E+3nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50140172(CHEBI:3962 | CHEMBL140 | Curcumin | US9409845, Tab...)
Affinity DataIC50:  8.65E+3nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424967(CHEMBL2316148 | US9409845, Table 1, Compound 9: (2...)
Affinity DataIC50:  1.53E+4nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM239058(US9409845, Table 1, Compound 17: (2E,6E)-2-di-(3,5...)
Affinity DataIC50:  1.87E+4nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Pharmaxyn Laboratories

US Patent
LigandPNGBDBM50424963(CHEMBL2316152 | US9409845, Table 1, Compound 13: (...)
Affinity DataIC50:  2.09E+4nMT: 2°CAssay Description:The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. T...More data for this Ligand-Target Pair
In DepthDetails US Patent